Takeda Pharmaceutical Co

Compliant

Under AAOIFI Standard 21, Takeda Pharmaceutical Co is compliant. Its core business is permissible and its interest-bearing debt is below 30% of market cap.

Ticker4502

ExchangeTSE

SectorGastroenterology & Rare Diseases

Full ratios for Takeda Pharmaceutical Co (impure revenue, debt and interest-bearing deposits under all four standards) are being added. Until then this page shows the screening verdict only. See the methodology for how each test works. Purindex publishes this screening to help people understand what they own. It does not recommend buying, selling or holding Takeda Pharmaceutical Co or any other security.